In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sekisui Chemical Co. Ltd.

www.sekisuichemical.com

Latest From Sekisui Chemical Co. Ltd.

Genzyme completes sale of pharmaceutical intermediates business to ICIG

Genzyme has completed the sale of its third and last non-core business area, as the transaction between Genzyme and International Chemical Investors Group (ICIG) for the pharmaceutical intermediates business has closed.

Switzerland

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2010

In the fourth quarter, medical device companies raised $1.1 billion, a third of which was represented by follow-on public offerings. Acquisitions were strong overall, holding steady with 15 transactions - the same as Q3 - but only slightly less in money paid, $6 billion. In vitro diagnostic/research companies, like medical device, also ended 2010 on a high note, with funding totaling $511 million in Q4. The majority of the money spent on IVD/research acquisitions came from Thermo Fisher Scientific's buy of Dionex for $2.1 billion.
Medical Device

Deals Shaping the Medical Industry (03/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Sekisui Chemical Co. Ltd.
  • Senior Management
  • Naofumi Negishi, Pres.
  • Contact Info
  • Sekisui Chemical Co. Ltd.
    Phone: (81) 3 5521 0522
    4-4, Nishitenma 2-chome, Kita-ku
    Osaka, 530-8565
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register